Production (Stage)
Cardiff Oncology, Inc.
CRDF
$3.86
$0.051.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 79.89M | 91.75M | 57.67M | 60.32M | 67.19M |
| Total Receivables | 405.00K | 1.17M | 618.00K | 451.00K | 393.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.42M | 2.14M | 1.05M | 1.48M | 2.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 82.71M | 95.05M | 59.33M | 62.25M | 69.99M |
|
|
|||||
| Total Current Assets | 82.71M | 95.05M | 59.33M | 62.25M | 69.99M |
| Net Property, Plant & Equipment | 1.84M | 2.07M | 2.30M | 2.53M | 2.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 257.00K | 69.00K | 1.27M | 1.27M | 1.28M |
| Total Assets | 84.81M | 97.19M | 62.90M | 66.05M | 74.04M |
|
|
|||||
| Total Accounts Payable | 3.63M | 4.82M | 4.64M | 5.11M | 5.19M |
| Total Accrued Expenses | 8.04M | 7.90M | 7.18M | 6.71M | 5.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 716.00K | 710.00K | 707.00K | 702.00K | 696.00K |
| Total Finance Division Other Current Liabilities | 902.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 902.00K | -- | -- | -- | -- |
| Total Current Liabilities | 13.29M | 13.43M | 12.53M | 12.52M | 11.84M |
|
|
|||||
| Total Current Liabilities | 13.29M | 13.43M | 12.53M | 12.52M | 11.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 640.00K | 813.00K | 979.00K | 1.14M | 1.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.93M | 14.24M | 13.50M | 13.66M | 13.14M |
|
|
|||||
| Common Stock & APIC | 468.46M | 467.09M | 421.70M | 413.02M | 409.79M |
| Retained Earnings | -397.61M | -384.18M | -372.39M | -360.54M | -348.76M |
| Treasury Stock & Other | 27.00K | 34.00K | 82.00K | -97.00K | -132.00K |
| Total Common Equity | 70.88M | 82.95M | 49.39M | 52.39M | 60.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 70.88M | 82.95M | 49.39M | 52.39M | 60.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 70.88M | 82.95M | 49.39M | 52.39M | 60.89M |
|
|
|||||